Edition:
United Kingdom

AxoGen Inc (AXGN.OQ)

AXGN.OQ on NASDAQ Stock Exchange Capital Market

33.51USD
19 Oct 2018
Change (% chg)

-- (--)
Prev Close
$33.51
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
128,569
52-wk High
$56.75
52-wk Low
$19.40

Chart for

About

AxoGen, Inc. offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane. Along... (more)

Overall

Beta: 0.32
Market Cap(Mil.): $619.93
Shares Outstanding(Mil.): 33.24
Dividend: --
Yield (%): --

Financials

  AXGN.OQ Industry Sector
P/E (TTM): -- 196.85 33.64
EPS (TTM): -0.43 -- --
ROI: -46.12 9.70 14.27
ROE: -195.07 15.72 15.99

BRIEF-Axogen Inc Announces Closing Of Public Offering Of Common Stock

* AXOGEN, INC. ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

14 May 2018

BRIEF-AxoGen Upsizes Public Offering To 3 Mln Shares At $41 Per Share

* AXOGEN, INC. ANNOUNCES UPSIZING AND PRICING OF PUBLIC OFFERING OF COMMON STOCK

09 May 2018

BRIEF-AxoGen Announces Proposed Public Offering Of Common Stock

* AXOGEN INC - COMMENCED AN UNDERWRITTEN PUBLIC OFFERING OF 2 MILLION SHARES OF ITS COMMON STOCK

07 May 2018

BRIEF-AxoGen Reports Q1 Loss Per Share Of $0.16

* FY2018 REVENUE VIEW $84.9 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

30 Apr 2018

Earnings vs. Estimates